795
Views
9
CrossRef citations to date
0
Altmetric
Reviews

CRISPR/Cas: from adaptive immune system in prokaryotes to therapeutic weapon against immune-related diseases

CRISPR/Cas9 offers a simple and inexpensive method for disease modeling, genetic screening, and potentially for disease therapy

ORCID Icon, &
Pages 11-20 | Received 02 Aug 2019, Accepted 01 Oct 2019, Published online: 18 Oct 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Himanshu Kumar. (2020) Therapeutic approaches for genetic and infectious diseases. International Reviews of Immunology 39:1, pages 1-2.
Read now

Articles from other publishers (8)

Chunyu Tong, Yimin Liang, Zhelin Zhang, Sen Wang, Xiaohui Zheng, Qi Liu & Bocui Song. (2023) Review of knockout technology approaches in bacterial drug resistance research. PeerJ 11, pages e15790.
Crossref
Muthukumaran Jayachandran, Zhaoliang Fei & Shen Qu. (2022) Genetic advancements in obesity management and CRISPR–Cas9-based gene editing system. Molecular and Cellular Biochemistry 478:3, pages 491-501.
Crossref
Juan Esteban Garcia-Robledo, Rafael Rosell, Alejandro Ruíz-Patiño, Carolina Sotelo, Oscar Arrieta, Lucia Zatarain-Barrón, Camila Ordoñez, Elvira Jaller, Leonardo Rojas, Alessandro Russo, Diego de Miguel-Pérez, Christian Rolfo & Andrés F. Cardona. (2022) KRAS and MET in non-small-cell lung cancer: two of the new kids on the ‘drivers’ block. Therapeutic Advances in Respiratory Disease 16, pages 175346662110660.
Crossref
Sadegh Shojaei Baghini, Zhanna R. Gardanova, Angelina Olegovna Zekiy, Navid Shomali, Foad Tosan & Mostafa Jarahian. (2021) Optimizing sgRNA to Improve CRISPR/Cas9 Knockout Efficiency: Special Focus on Human and Animal Cell. Frontiers in Bioengineering and Biotechnology 9.
Crossref
Muhammad Sadeqi Nezhad, Mahboubeh Yazdanifar, Meghdad Abdollahpour‐Alitappeh, Arash Sattari, Alexander Seifalian & Nader Bagheri. (2021) Strengthening the CAR‐T cell therapeutic application using CRISPR/Cas9 technology. Biotechnology and Bioengineering 118:10, pages 3691-3705.
Crossref
Fen Wan, Mohamed S. Draz, Mengjie Gu, Wei Yu, Zhi Ruan & Qixia Luo. (2021) Novel Strategy to Combat Antibiotic Resistance: A Sight into the Combination of CRISPR/Cas9 and Nanoparticles. Pharmaceutics 13:3, pages 352.
Crossref
Han Yang, Shuling Ren, Siyuan Yu, Haifeng Pan, Tingdong Li, Shengxiang Ge, Jun Zhang & Ningshao Xia. (2020) Methods Favoring Homology-Directed Repair Choice in Response to CRISPR/Cas9 Induced-Double Strand Breaks. International Journal of Molecular Sciences 21:18, pages 6461.
Crossref
Ithzayana Madariaga-Perpiñan, Juan Camilo Duque-Restrepo, Paola Ayala-Ramirez & Reggie García-Robles. (2020) La edición del ADN. Iatreia 33:3, pages 262-272.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.